Format

배터리바둑이주소

Choose Destination
홀덤 카페 1995;13(2):94-7.

온라인카지노-코인카지노-바카라 돈 따는 법〈akaxx.com〉‹›☼일본 야마토 게임➴텍사스 홀덤 족보⇄룰렛이벤트▼솔레어카지노☜토토사이트

온라인카지노-코인카지노-라스베가스 카지노 슬롯 머신〈akaxx.com〉‹›►카지노 가입↷실전바둑이사이트↪바카라 시스템 배팅♦바다이야기 릴게임1카지노 도박

1
Department of Urology, University of Bochum, Marienhospital, Herne, Germany.

온라인카지노-코인카지노-카지노 잭팟〈akaxx.com〉‹›π바카라 가입머니➶온라인바카라 조작☍온라인 카지노 커뮤니티↤야마토 2 게임 하기ν마닐라 카지노 위치

Laser treatment has become increasingly attractive for treatment of bladder-outlet obstruction due to benign prostatic hyperplasia (BPH). However, it is unknown whether laser treatment may be as effective as transurethral resection of the prostate (TURP), how long effective treatments may last, and whether there may be substantial differences with respect to clinical outcome between different laser treatment modalities currently under clinical investigation. TULIP (transurethral ultrasound-guided laser-induced prostatectomy) was one of the very first laser systems designed for treatment of BPH. The procedure is performed exclusively under transurethral ultrasound guidance, with which the surgeon has to become familiar. However, data reported from single-institution as well as multicenter studies demonstrate that the technique has only a small learning curve. The majority of patients treated by TULIP will experience substantial improvements in subjective and/or objective symptoms, which nevertheless do not appear to be as good as those seen after TURP. This is also shown by data from a prospective and randomized TULIP versus TURP study. However, it has to be emphasized that the clinical significance of such differences remains unknown. Advantageous for TULIP (which may be performed under analgosedation) are reduced blood loss, hospitalization, and rate of postoperative sexual dysfunction. Disadvantageous (as compared with TURP) are the delayed onset of success combined with the prolonged catheterization time and irritative symptoms in the early postoperative phase. In addition, as no tissue is obtained for histology examination, incidental prostate cancer may be missed.

PMID:
7542972
[Indexed for MEDLINE]

온라인카지노-코인카지노-바카라 보는곳〈akaxx.com〉‹›↼바카라 무료 쿠폰↘바다이야기 고래➹카지노 바카라φ세계 카지노 순위♡도박 합법 국가

온라인카지노-코인카지노-카지노 양방〈akaxx.com〉‹›カ카지노 룰렛 전략☯황금성 다운로드╘인터넷 카지노 추천┌카지노 검증사이트↥카지노 양방

온라인카지노-코인카지노-바카라 먹튀 사이트〈akaxx.com〉‹›ナ강원 랜드 vip♡인터넷카지노사이트↾강원도 정선 카지노♡바카라 양방┷포커 규칙

블랙 잭 규칙
jnice02-ina17-ad-wb-0280